Nebzmart-G 25mcg Smartules 2ml
By Nebzmart-G
Rx
8 Respules in a Packet

Composition
Glycopyrrolate(25mcg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
May, 2026

liver
Caution is advised when using Nebzmart-G 25mcg Smartules 2ml in relation to liver health. As of current data, there are no known interactions or established concerns specifically related to the liver with this medication. However, it is always important to be cautious with any medication, as individual reactions can vary. If you have any existing liver conditions or concerns, it is recommended to consult with your doctor before using Nebzmart-G 25mcg Smartules 2ml for proper guidance and to ensure the safety and effectiveness of the treatment.

kidney
No interaction with kidney found, consult doctor for safety.

alcohol
Consult your doctor when consuming alcohol with Nebzmart-G 25mcg Smartules 2ml.

driving
When taking Nebzmart-G 25mcg Smartules 2ml, it is safe to drive as no interactions affecting driving have been established. Drive with caution.

pregnancy
Nebzmart-G 25mcg Smartules 2ml is generally safe to use during pregnancy as per animal studies. Limited human studies available.

breastfeeding
Nebzmart-G 25mcg Smartules 2ml is considered safe during breastfeeding based on limited human data. It poses minimal risk to the baby, but long-term use may decrease milk production.
Habit Forming | No |
Chemical Class | Synthetic Quaternary Ammonium |
Therapeutic Class | - |
Action Class | Anticholinergic - Anaesthesia |
₹453.6
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024